Metallopeptidase inhibitor 1 (TIMP‐1) promotes receptor tyrosine kinase c‐Kit signaling in colorectal cancer

Colorectal cancer (CRC) is the third most prevalent cancer worldwide causing an estimated 700 000 deaths annually. Different types of treatment are available for patients with advanced metastatic colorectal cancer, including targeted biological agents, such as cetuximab, a monoclonal antibody that t...

Descripción completa

Detalles Bibliográficos
Autores principales: Nordgaard, Cathrine, Doll, Sophia, Matos, Ana Laura de Souza Almeida, Høeberg, Mikkel, Uddin Kazi, Julhash, Friis, Stine, Stenvang, Jan, Rönnstrand, Lars, Mann, Matthias, Manuel Afonso Moreira, José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887592/
https://www.ncbi.nlm.nih.gov/pubmed/31545548
http://dx.doi.org/10.1002/1878-0261.12575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887592/
https://www.ncbi.nlm.nih.gov/pubmed/31545548
http://dx.doi.org/10.1002/1878-0261.12575

Ejemplares similares